Discontinuation report LIORESAL D.S. TAB 20MG
Report ID | 103075 |
Drug Identification Number | 00636576 |
Brand name | LIORESAL D.S. TAB 20MG |
Common or Proper name | LIORESAL D.S. 20MG CT 100'S |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | BACLOFEN |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100'S |
ATC code | M03BX |
ATC description | MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2020-01-31 |
Actual discontinuation date | 2020-01-31 |
Remaining supply date | 2020-01-31 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | Lot on remaining supply expires June 30, 2020 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2020-02-24 | French | Compare |
v3 | 2020-02-24 | English | Compare |
v2 | 2020-01-10 | French | Compare |
v1 | 2020-01-10 | English | Compare |
Showing 1 to 4 of 4